Defined scenarios | PCV-2 IgG ELISA S/P ratio before vaccination (3–4 woa) | |||
---|---|---|---|---|
2020 | 2022 | |||
X̅ ± SD | CV (%) | X̅ ± SD | CV (%) | |
POS20-POS22 | 0.397 ± 0.197 a A | 49.1 | 0.599 ± 0.372 a A | 62.0 |
POS20-NEG22 | 0.549 ± 0.203 a AB | 37.0 | 0.686 ± 0.263 a A | 38.4 |
NEG20-POS22 | 0.628 ± 0.286 a B | 45.5 | 0.476 ± 0.275 b A | 57.9 |
NEG20-NEG22 | 0.639 ± 0.342 a B | 53.4 | 0.531 ± 0.284 a A | 53.6 |
Total | 0.598 ± 0.315 | 56.6 | 0.530 ± 0.298 | 56.1 |